Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study
Clinical trial NCT04872582 · UNKNOWN
Trial details
- NCT number
- NCT04872582
- Sponsor
- XIANG YANQUN
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-29
- Primary completion
- 2023-01-04
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.